X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AMAR REMEDIES with Hindustan Unilever - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs HIND. UNILEVER - Comparison Results

HIND. UNILEVER 
   Change

HUL, the largest FMCG company in the country constitutes 13% of the industry valued at Rs. 1.6 trillion (AC Nielsen). It is present in over 20 distinct categories in Home & Personal Care Products and Foods & Beverages. Revenue share of the various pr... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES HIND. UNILEVER AMAR REMEDIES/
HIND. UNILEVER
 
P/E (TTM) x -0.5 61.5 - View Chart
P/BV x 0.1 43.7 0.1% View Chart
Dividend Yield % 0.0 1.2 -  

Financials

 AMAR REMEDIES   HIND. UNILEVER
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
HIND. UNILEVER
Mar-17
AMAR REMEDIES/
HIND. UNILEVER
5-Yr Chart
Click to enlarge
High Rs164954 17.2%   
Low Rs86783 11.0%   
Sales per share (Unadj.) Rs261.6153.2 170.7%  
Earnings per share (Unadj.) Rs17.420.8 83.6%  
Cash flow per share (Unadj.) Rs22.322.8 97.7%  
Dividends per share (Unadj.) Rs017.00 0.0%  
Dividend yield (eoy) %02.0 0.0%  
Book value per share (Unadj.) Rs100.731.2 323.2%  
Shares outstanding (eoy) m26.162,163.94 1.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.55.7 8.4%   
Avg P/E ratio x7.241.7 17.2%  
P/CF ratio (eoy) x5.638.1 14.7%  
Price / Book Value ratio x1.227.9 4.5%  
Dividend payout %081.7 0.0%   
Avg Mkt Cap Rs m3,2701,879,382 0.2%   
No. of employees `000NANA-   
Total wages/salary Rs m16317,430 0.9%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m6,844331,620 2.1%  
Other income Rs m213,690 0.6%   
Total revenues Rs m6,865335,310 2.0%   
Gross profit Rs m1,13163,400 1.8%  
Depreciation Rs m1284,320 3.0%   
Interest Rs m398350 113.7%   
Profit before tax Rs m62662,420 1.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-502,370 -2.1%   
Tax Rs m12119,770 0.6%   
Profit after tax Rs m45545,020 1.0%  
Gross profit margin %16.519.1 86.4%  
Effective tax rate %19.331.7 61.0%   
Net profit margin %6.613.6 49.0%  
BALANCE SHEET DATA
Current assets Rs m4,90476,770 6.4%   
Current liabilities Rs m3,58177,140 4.6%   
Net working cap to sales %19.3-0.1 -17,325.6%  
Current ratio x1.41.0 137.6%  
Inventory Days Days12428 444.3%  
Debtors Days Days10012 838.7%  
Net fixed assets Rs m1,68946,480 3.6%   
Share capital Rs m2622,160 12.1%   
"Free" reserves Rs m2,35865,280 3.6%   
Net worth Rs m2,63567,440 3.9%   
Long term debt Rs m5072,770 18.3%   
Total assets Rs m6,862157,060 4.4%  
Interest coverage x2.6179.3 1.4%   
Debt to equity ratio x0.20 468.5%  
Sales to assets ratio x1.02.1 47.2%   
Return on assets %12.428.9 43.0%  
Return on equity %17.366.8 25.9%  
Return on capital %31.092.8 33.4%  
Exports to sales %4.00-   
Imports to sales %00-   
Exports (fob) Rs m273NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m2735,410 5.0%   
Fx outflow Rs m212,140 0.0%   
Net fx Rs m271-6,730 -4.0%   
CASH FLOW
From Operations Rs m-31351,850 -0.6%  
From Investments Rs m-489-11,730 4.2%  
From Financial Activity Rs m769-42,140 -1.8%  
Net Cashflow Rs m-33-2,020 1.6%  

Share Holding

Indian Promoters % 25.5 0.0 -  
Foreign collaborators % 0.0 67.3 -  
Indian inst/Mut Fund % 9.2 4.1 224.4%  
FIIs % 0.0 14.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 14.5 450.3%  
Shareholders   13,061 322,351 4.1%  
Pledged promoter(s) holding % 99.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   BAJAJ CORP  GODREJ CONSUMER  MARICO LTD  P&G HYGIENE  LINC PEN & PLASTICS LTD  

Compare AMAR REMEDIES With:   P&G (US)  UNILEVER PLC. (UK)  HYPERMARCAS (Brazil)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 8-QTR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS